top of page
Search
Gustavo Dziewczapolski, Scientific Director
Sep 235 min read
Research Update: LMNA
We are honored to support groundbreaking discoveries related to LMNA-CMD.
Gustavo Dziewczapolski, Scientific Director
Aug 73 min read
Research Update: Dystroglycanopathy
We are honored to support groundbreaking discoveries related to Dystroglycanopathy.
Gustavo Dziewczapolski, Scientific Director
Jul 24 min read
Research Update: LAMA2
We are honored to support groundbreaking discoveries related to LAMA2-Related Dystrophy.
Gustavo Dziewczapolski, Scientific Director
Jun 62 min read
iMM Joins the MAGIC Consortium to Advance Research on Muscular Dystrophies
The MAGIC research team welcomes iMM to the consortium to add a cellular perspective to muscle-on-chip technologies
Gustavo Dziewczapolski, Scientific Director
May 284 min read
Research Update: SELENON
We are honored to support groundbreaking discoveries related to SELENON-Related Disorders.
Giulia Da Re
May 2318 min read
Interview with Gustavo Dziewczapolski: Doctor in Neuropharmacology and Scientific Director of Cure CMD
Explore an in-depth interview with Gustavo Dziewczapolski, Doctor in Neuropharmacology and Scientific Director of Cure CMD. Gain insights in
Gustavo Dziewczapolski, Scientific Director
May 12 min read
2024 Myology Congress Recap
Cure CMD’s Scientific Director, Dr. Gustavo Dziewczapolski, provides a recap of his attendance at the 8th International Myology Congress in
Gustavo Dziewczapolski, Scientific Director
Apr 164 min read
Research Update: Collagen 6
We are honored to support groundbreaking discoveries in Collagen 6-Related Dystrophies (COL6-RD).
Cure CMD
Nov 12, 20196 min read
2019 SciFam Lay Summary: Stronger Together
A “Triad” of patient advocacy organizations for ultra-rare congenital muscular diseases, Cure CMD (Congenital Muscular Dystrophy), A...
Cure CMD
Nov 10, 20171 min read
Cure CMD's 5-Year Research Goals
Cure CMD has achieved significant impact in its first nine years as the only nonprofit organization in the U.S. dedicated specifically to...
Cure CMD
Jan 8, 20173 min read
2017 Kicks Off with New Treatments for Pediatric Neuromuscular Disorders
The last week of December 2016 finds us with the first and second ever FDA-approved treatments for two groups of affected individuals...
Cure CMD
Oct 1, 20161 min read
Introducing Cure CMD's new Scientific Director
Dear CMD Community, I am delighted to join Cure CMD as the new Scientific Director. I am eager to build on the legacy of strong...
bottom of page